Katarzyna Michalska-Malecka_SCIENTIFIC POSTER 2015

The Aim:

The aim of the research was to evaluate the influence of ocriplasmin intravitreal injection on the changes in vitreomacular traction and on improvements in visual acuity.

Patients & Methods:

The analysis included patients who were treated in the University Centre of Ophthalmology and Oncology, Independent Public Clinical Hospital, Medical University of Silesia in Katowice, and who have been diagnosed with vitreomacular traction. Before and after the ocriplasmin injection, patients were examined with: visual acuity test, measurement of intraocular pressure, retinal optical coherence tomography, ultrasonography and ultrabiomicroscopy examinations, visual field test, and fundus image. Additional check-ups were made on 1st, 14th and 28th day after the surgery.


The analysis of data, obtained from examination of patients who have undergone ocriplasmin injection, revealed in some patients the improvement of visual acuity, reduction of traction changes as well as improvement of central retina morphology. Conclusions: The use of ocriplasmin intravitreal injection in patients with symptomatic VMT in some cases has a positive influence on vision and allows to avoid vitrectomy.

Contact Details:

Email: k.michalska.malecka@gmail.com
Cell Phone: +48600064150